{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:05:14Z","timestamp":1778659514539,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","award":["R01 1R01EY025304-01"],"award-info":[{"award-number":["R01 1R01EY025304-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["theocularsurfacejournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jtos.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T12:17:52Z","timestamp":1526473072000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis"],"prefix":"10.1016","volume":"16","author":[{"given":"Hui","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-6215","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva P.","family":"Kambhampati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-2999","authenticated-orcid":false,"given":"Chih-Chien","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangaramanujam M.","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel C.","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2018.05.004_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.exger.2012.03.020","article-title":"Aging and dry eye disease","volume":"47","author":"Ding","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jtos.2018.05.004_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","article-title":"Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life","volume":"157","author":"Paulsen","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib3","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jtos.2018.05.004_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jtos.2018.05.004_bib5","first-page":"58","article-title":"Sjogren's syndrome: from pathogenesis to novel therapeutic targets","volume":"34","author":"Barone","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jtos.2018.05.004_bib6","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2018.05.004_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1834-7819.2010.01197.x","article-title":"Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management","volume":"55","author":"Bayetto","year":"2010","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jtos.2018.05.004_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2008.04.019","article-title":"Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens","volume":"31","author":"Thomas","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jtos.2018.05.004_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-0124(12)70289-6","article-title":"Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease","volume":"7","author":"Nguyen","year":"2009","journal-title":"Ocul Surf"},{"issue":"Suppl:S57","key":"10.1016\/j.jtos.2018.05.004_bib10","article-title":"Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations","volume":"103","author":"von Bultzingslowen","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jtos.2018.05.004_bib11","first-page":"1447","article-title":"Managing Sjogren's Syndrome and non-Sjogren Syndrome dry eye with anti-inflammatory therapy","volume":"8","author":"Coursey","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0161-6420(95)30971-2","article-title":"Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging","volume":"102","author":"Obata","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.05.004_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/ICO.0b013e31823f8e47","article-title":"Autoimmune dacryoadenitis and sialadenitis induced in rabbits by intravenous injection of autologous lymphocytes activated ex vivo against lacrimal antigens","volume":"31","author":"Wei","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.05.004_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/exer.2000.0855","article-title":"Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits","volume":"71","author":"Guo","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2018.05.004_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1542-0124(12)70222-7","article-title":"A\u00a0lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human","volume":"8","author":"Schechter","year":"2010","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.05.004_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jop.2008.0138","article-title":"Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis","volume":"25","author":"Thomas","year":"2009","journal-title":"J\u00a0Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2018.05.004_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","article-title":"Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye workshop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.05.004_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1631\/jzus.2006.B0675","article-title":"A\u00a0clinical study of the efficacy of topical corticosteroids on dry eye","volume":"7","author":"Yang","year":"2006","journal-title":"J\u00a0Zhejiang Univ Sci B"},{"key":"10.1016\/j.jtos.2018.05.004_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1542-0124(12)70005-8","article-title":"Anti-inflammatory therapy of dry eye","volume":"1","author":"Pflugfelder","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.05.004_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sjopt.2013.12.003","article-title":"Recent developments on dry eye disease treatment compounds","volume":"28","author":"Colligris","year":"2014","journal-title":"Saudi J Ophthalmol Off J Saudi Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2018.05.004_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2010.0085","article-title":"Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease","volume":"27","author":"Sheppard","year":"2011","journal-title":"J\u00a0Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2018.05.004_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.05.004_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.02.016","article-title":"Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation","volume":"125","author":"Soiberman","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2018.05.004_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.jtos.2018.05.004_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2014.10.035","article-title":"Corneal targeted nanoparticles for sustained natamycin delivery and their PK\/PD indices: an approach to reduce dose and dosing frequency","volume":"477","author":"Chandasana","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2018.05.004_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biomaterials.2011.10.010","article-title":"Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration","volume":"33","author":"Iezzi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2018.05.004_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","article-title":"Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications","volume":"15","author":"Menjoge","year":"2010","journal-title":"Drug Discov Today"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2018.05.004_bib28","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0169-409X(01)00184-3","article-title":"Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas","volume":"50","author":"Florence","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2018.05.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/153535003765276237","article-title":"Dendrimer-based macromolecular MRI contrast agents: characteristics and application","volume":"2","author":"Kobayashi","year":"2003","journal-title":"Mol Imag"},{"key":"10.1016\/j.jtos.2018.05.004_bib30","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/nbt1171","article-title":"Designing dendrimers for biological applications","volume":"23","author":"Lee","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtos.2018.05.004_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002212","article-title":"A\u00a0phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis","volume":"3","author":"Hayder","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtos.2018.05.004_bib32","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2018.05.004_bib33","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1021\/mp400371r","article-title":"Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation","volume":"10","author":"Lesniak","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jtos.2018.05.004_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2004.09.015","article-title":"Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide","volume":"102","author":"Vandamme","year":"2005","journal-title":"J\u00a0Contr Release Off J Control Rel Soc"},{"key":"10.1016\/j.jtos.2018.05.004_bib35","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.biomaterials.2007.08.041","article-title":"Designing hydrogel adhesives for corneal wound repair","volume":"28","author":"Grinstaff","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2018.05.004_bib36","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/sj.gt.3302579","article-title":"Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity","volume":"12","author":"Marano","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtos.2018.05.004_bib37","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.05.004_bib38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.05.004_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-13-50","article-title":"Establishment of the mild, moderate and severe dry eye models using three methods in rabbits","volume":"13","author":"Li","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajo.2016.04.020","article-title":"Clinical efficacy and safety of ranibizumab versus dexamethasone for central retinal vein occlusion (COMRADE C): a European label study","volume":"169","author":"Hoerauf","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib41","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/nn404872e","article-title":"Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest","volume":"8","author":"Mishra","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2018.05.004_bib42","first-page":"240","article-title":"Dry eye: an inflammatory ocular disease","volume":"9","author":"Hessen","year":"2014","journal-title":"J\u00a0Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2018.05.004_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","article-title":"Antiinflammatory therapy for dry eye","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.05.004_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A\u00a0randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.05.004_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713683.2011.574330","article-title":"Changes of aquaporins in the lacrimal glands of a rabbit model of Sjogren's syndrome","volume":"36","author":"Ding","year":"2011","journal-title":"Curr Eye Res"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418300235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418300235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T03:32:35Z","timestamp":1538623955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012418300235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1542012418300235"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2018.05.004","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}